DatasetName,GATAD2A_S(100) GATAD2A_S(107) GATAD2A_S(113) GATAD2A_S(114) GATAD2A_S(26) GATAD2A_S(340) GATAD2A_S(521) GATAD2A_S(523) GATAD2A_S(529) GATAD2A_S(546) GATAD2A_S(548) GATAD2A_S(554) GATAD2A_S(556) GATAD2A_S(96) GATAD2A_T(189) GATAD2A_T(327) GATAD2A_T(42) GATAD2A_T(47) GATAD2A_T(49) GATAD2A_T(57) GATAD2A_T(586),GATAD2A_M(49) GATAD2A_S(315) GATAD2A_S(512) GATAD2A_S(547) GATAD2A_S(549) GATAD2A_S(598) GATAD2A_S(599) GATAD2A_T(544) GATAD2A_T(587)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5217519572795679,0.35705349527599367
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5328955183833641,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5373714756458043,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5354319911661682,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.541070958602949,
ZX2022_Control Replicate 2,0.5275381589412166,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,0.5313537961255276,
FSO2013_Ratio M/L normalized Rep1,0.5480689627692455,0.36929301135088255
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5282900492381117,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5346963026692967,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5566965306716704,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5438115138845617,0.369532747064492
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5352403113926631,
WZ2023_Pu_010_30min,0.5436357691771256,0.3534246676393903
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.535271777977233,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5363467751105556,
FSO2013_Ratio M/L normalized Rep3___3,0.5373954994060544,
AH2018_TMTMS3_1_C,0.5315049468515995,0.36194912172731025
JJ2018_Ratio H/L normalized___1,0.5263329920010571,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5160396982717547,
AH2018_SILAC_MR_2_N,0.5315275379455158,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.554722306171131,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.5348441757666075,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5115468132232176,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5384384238043745,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5300916915251019,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5466410327448847,0.3727402373537489
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.5573202122877818,
KBE2022_Log2_Ex_34_U,0.5369679535835792,
WZ2023_Pu_005_10min,0.539761867310955,0.3647182860750922
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5351197193261426,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.5361400402979702,
WZ2023_Pu_025_30min,0.5366195718973485,0.3405930802084225
AH2018_SILAC_MR_2_X,0.5329213031949849,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5538475721466732,0.4037203427823308
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5791256833990007,0.40004307345563705
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,0.5210898359785219,
AH2018_SILAC_3_X,0.5219678412724205,
JJ2018_Ratio M/L normalized pP3,0.529311248412917,
AH2018_SILAC_M_2_N,0.5237594374993875,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5185028165581824,0.38602115832890177
AH2018_LFQ_1_C,0.5380314353625406,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5450209906092212,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5505408676812054,0.37916900178102825
CK2022_11 40-1,0.5339467994296951,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5257802298349716,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5523352982488893,
FSO2013_Ratio H/L normalized Rep2,0.5372656215527548,0.37625965322013705
WZ2023_Pu_005_20min,0.5437226791496383,0.36088485230054534
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5609560636896991,0.3971053612517613
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5381340054943584,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.5245030335151741,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5288440454758451,
CK2022_1 200-1,0.5542815539240824,
PG2020_Intensity Mock_10h_D,0.5153963816223626,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5263841440722564,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.5417164349898898,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.556724887464229,0.3912911192482969
PG2020_Intensity 2h_C,0.5109104181612844,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5262098176256574,
KBE2022_Log2_Ex_8_T,0.5316441809950312,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5298048565043361,
CK2022_3 40-1,0.5315445427900481,
RBK2021_1260T Early,0.535367433469701,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5514145489038285,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5257473335336046,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5198736065894998,
YA2020_Reporter_intensity_Normal_No.1,0.5484962217732532,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5425105661786856,0.37723769916896277
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,0.5363752965726226,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5419585169622282,
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.5360149859103691,
HS2024_6_PD_T3,,
DL2023_12h-2,0.5411072356230211,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5396802741688652,0.35362788300642894
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5310065695534795,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5324793863088562,
KS2014_Intensity N3,0.5650994250707557,0.39014670784585725
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5329115884211405,
FSO2013_Ratio H/M normalized Rep2,0.5141418124393657,0.35778097028783395
RAM2015_Log2 A,0.5516511608654342,0.38809891482026093
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.5388320586324821,
CF2017_OSE 27,0.5320160595055393,
KS2014_Intensity E15_2,0.5453126090821634,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5407676856261416,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5356927261834917,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5228397479631279,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5448291322939015,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5343292633707469,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.5565092441128298,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5367594694315184,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5275959905375817,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,0.5277007204169183,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5252972844682182,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5383846363642493,
FSO2013_Ratio M/L normalized Rep2,0.5257257650235183,0.35327706318502006
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5326211151900149,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5320489732820841,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.51849451868475,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5283949755923186,
DL2023_control-1,0.5396604275722579,
AR2021_ALG 10 μM,0.5769446580016957,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5243084616931879,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5345684837039274,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5337709390712505,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5426669671462746,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.541172360920946,
JW2021_After_3,,
GF2025_P8_Sph,0.5329578342713697,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5383551744577934,
AH2018_SILAC_2_N,0.5224645706851078,
CK2022_11 200-1,0.5571919419917583,
CK2022_12 200-1,0.554873131767367,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5311176883443484,
WZ2023_Su_010_20min,0.546815927867502,0.3660170831783048
AH2018_TMTMS2_2_N,0.5381269066159836,0.3687116539786684
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5370926796105875,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5257946998130334,
KS2014_Intensity N4,0.5619689798853464,0.38720661064110184
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5345325742972191,
CK2022_14 200-1,0.557712291310363,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.527675934627099,
AST2020_anti-CD3+PDL2.2,0.5569193089165579,
PG2020_Intensity Mock_10h_A,0.5103439107214484,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5290566830422286,
GF2025_P1_Adh,0.5306396047003412,
GF2025_P1_Sph,0.5318835098170721,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5516935508905165,0.3830595781395779
CF2017_EOC 1,0.5442547907677922,
CK2022_3 200-1,0.5545727289684281,
AH2018_LFQ_IT_3_C,0.5296860547440329,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.5416916147133006,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5310129806883019,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.555578735301283,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.531891729176022,
AR2021_ALG 1 μM,0.5334474261403125,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5607905137276804,0.3721673673343575
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5388767868372012,
CK2022_9 16-1,0.5314366935300392,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,0.534623501100558,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5580704688529644,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5314794042873867,
CK2022_16 16-1,0.5286883588326405,
FS2019_db/db3,,
CK2022_15 40-1,0.5331023131272347,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5437906966950304,0.35549134005336
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5355400908127301,
AMK2021_Ctrl_p1,0.5359069535415761,
AH2018_LFQ_IT_3_X,0.5257439384131489,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5282308378521416,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5352663054051705,
AH2018_LFQ_M_1_N,0.5349559398422971,
KBE2022_Log2_Ex_27_U,0.5286177925703711,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5348139056885005,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.551985311127177,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.48738713249055365,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5286734582757762,
RN2012_L13,0.5345834150061798,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5295577437842711,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5192254849391359,0.35995442927478744
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5349381153834346,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5272532460535436,
HH2022_Reporter intensity 6,0.5238857077388475,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5422451498717296,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5314401894478176,0.3583988875091493
GF2025_P3_Adh,0.5367377036311374,
SR2019_JIMT1_Biol_repl_2,0.5394162160695836,
AH2018_TMTMS2_1_C,0.5392190580995652,0.36291707027910813
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5434285298668897,
KBE2022_Log2_Ex_19_U,0.5375992210301233,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.528938672901418,
YA2020_Reporter_intensity_Cancer_No.1,0.5453633134761718,
AST2020_Control,0.5548016337509798,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5338017307073003,0.35340800009705986
LG2023_Control-2_intensity,0.5395813383978654,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,0.5227912343716377,
YA2020_Reporter_intensity_Normal_No.3,0.5544762828282749,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5328253263676894,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5671381949816305,0.3840074944438594
HH2022_Reporter intensity 1,0.5422918860680497,0.3721560003777529
HH2022_Reporter intensity 2,0.5423067906141005,0.36958436158443786
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5502515646001487,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.528728290739582,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5477105402301716,0.37030476077285446
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5221260734037525,0.3760904720316962
AR2021_KD 72h,0.5278911349790826,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5315928870739419,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5292014821466243,
KBE2022_Log2_Ex_9_U,0.5330771962496362,
AH2018_SILAC_M_3_N,0.5208016024302047,
KBE2022_Log2_Ex_13_T,0.5340582431437333,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5090357507618052,
CF2017_OSE 29,0.535182523803927,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5418217444621989,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5363904646052289,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5255017303102973,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5268625408835576,0.36292058972782393
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5339686249187439,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5329443959558445,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.48659666190007106,
FSO2013_Ratio H/M normalized Rep2___2,0.5305242719461846,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5349122479232145,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5541524504893923,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.556360364726386,
CK2022_5 200-1,0.5565909108656343,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5368194692992406,0.3763925658474031
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5332954472607211,
AH2018_SILAC_MR_1_X,0.5302073903396002,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5354386682491195,
AH2018_SILAC_3_C,0.5232230182050529,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5213545732370355,0.36114217071816584
CK2022_4 16-1,0.5268754410966165,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5296642303143163,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5218535648031963,0.3749307211682743
JJ2018_Ratio M/L normalized pP2,0.5383559894484432,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5342982670335245,
FSO2013_Ratio H/L normalized Rep3,0.5555593393713747,0.38569329784142337
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5335152544696963,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5333320002915194,
AH2018_SILAC_IT_2_N,0.5248461467958503,
AH2018_SILAC_IT_1_X,0.5280875355321843,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5425022468746834,
WZ2023_Pe_025_20min,0.5492999907492693,0.36568750803296785
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5362132087330835,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.533877610408154,0.3673120181357674
RN2012_H06,0.5365199970524293,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5451536006685594,0.3536393673156098
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.5356444559603505,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5434271935660855,0.38476818595912615
WZ2023_Su_025_10min,0.5440966561755636,0.36459294009381815
AH2018_LFQ_IT_4_X,0.5242562641725975,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5454556166467055,0.3611240714008951
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5541262097472638,0.389704781331617
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.5320951355367747,
EP2017_Pervanadate R#1 log2 ratio,0.525944395482495,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5597906251755473,0.3841044491509662
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5222603457514425,
LY2019_P7+,0.522134334653227,
EP2017_Untreated R#1 normalized log2 ratio,0.5190707955469238,
RN2012_L10,,
PG2020_Intensity 4h_C,0.51887787803136,
EP2017_Mitotic R#3 normalized log2 ratio,0.5306933787829686,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5342035420673815,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5258125898069592,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5388910103155717,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5399703320798765,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.5409070529852781,
CR2017_Ratio Replicate 1.1,0.542778202855123,0.3737777471448774
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5579871687666849,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5287445916858294,
GF2025_P9_Sph,0.5372600174129489,
CK2022_6 200-1,0.556698020138804,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.533591336472626,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5153875531435202,
EP2017_Untreated R#3 normalized log2 ratio,0.5680101744109829,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5567030928311992,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5493645468580708,0.37659538052817687
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5310680885688192,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5021069391795485,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5297058988344013,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5319007622073104,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,0.5370196243299659,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5341060354385894,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5321852838819431,
PG2020_Intensity CT_C,0.5145706523567883,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5415834229879456,
EP2017_Untreated R#3 log2 ratio,0.570026279717407,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.540630431024748,0.3647565393527942
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5400757687328912,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5696363780392171,0.3833342787183398
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5327193297956884,
YA2020_Reporter_intensity_Normal_No.2,0.547985067629782,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,0.5259229611135292,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5562868024036189,0.36174804562470125
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.5000765571505651,
AH2018_LFQ_M_2_N,0.5401255312985265,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5346745458292774,
CK2022_2 16-1,0.5278249576907975,
RAM2015_Log2 B,0.5580806961648614,0.36302928740150053
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5411207118313204,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5370967434885735,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.5403217447708814,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5134002491233944,
WZ2023_Su_025_30min,0.5448637272547059,0.3593830121137131
AH2018_LFQ_4_N,0.5355164839551667,
CR2017_Ratio Replicate 1.2,0.5439363760311329,0.383173999184821
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,0.524484338283966,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5296920883538531,
AH2018_SILAC_M_1_X,0.5380800382180485,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.5410988942679958,
LY2019_P6+,0.539201378363377,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5360610950638518,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5280435041496185,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5434967504921471,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5346251720080963,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5342958035267497,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5281538138971618,
AH2018_LFQ_2_X,0.5286773085798165,
PG2020_Intensity 2h_B,0.5135084329189985,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5522469809595909,
GF2025_P3_Sph,0.5309741913961404,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5374056327800351,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5265921399082062,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5259771443934641,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5357697187204042,
CR2017_Ratio Replicate 2.4,0.5261573480789435,0.36940530025403123
ZQ2022_N1,,
LY2019_P6-,0.5399167225313702,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5335491889334258,
AH2018_LFQ_3_N,0.5346853735412604,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5247061210920405,0.38896185744539435
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5334391282984472,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5311132706171813,
CK2022_7 40-1,0.5342189111784821,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5151494955943254,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5265596161024279,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5424138097973634,0.3542534965002912
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5211487709294184,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5171179091810808,0.3846833215475095
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.534073957222954,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.5351564419412373,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.516836588035547,
FSO2013_Ratio M/L normalized Rep1___3,0.529692287216375,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5292773726980001,
AH2018_LFQ_M_4_C,0.5360921556993239,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.5405294688594917,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5410050438261743,
CK2022_6 40-1,0.5340015365570479,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.540171348044692,
LY2019_P3-,0.5322158085014467,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5527053019505165,0.3832023922882802
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.5555826172505547,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.522403988099104,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.544689459647052,0.35742277392563754
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5437234459606454,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,0.5352880085598228,
AH2018_TMTMS2_2_C,0.542145783844158,0.36397843694544246
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5241972579233811,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5416653550351762,
LY2019_P8+,0.5323015333650554,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5354451554082542,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5375774712784649,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5450839344478964,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5323915003306647,
LY2019_P2-,0.5185774717310947,
AH2018_LFQ_IT_1_X,0.5362732080377229,
JJ2018_Ratio H/L normalized pP3___1,0.5310361916636384,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5524971555210103,0.37644769935643946
AST2020_Control.2,0.5560999827587898,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5313614149795264,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,0.5277895171029231,
KBE2022_Log2_Ex_36_U,0.5297362936272131,
AH2018_TMTMS3_3_N,0.5248296839051618,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5351643526558035,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5335599034977713,
KBE2022_Log2_Ex_36_T,0.5291973781873347,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5464955750346346,0.35572603439310924
KS2014_Intensity C2,0.5391533255585418,
FSO2013_Ratio H/L normalized Rep1___2,0.5407156701467793,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.542389615696507,
CK2022_9 200-1,0.5561448183426084,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5568521329700419,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,0.530436440967431,
LY2019_P1-,0.5373742499515924,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5558817953074053,0.37133568552872864
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5488629876994524,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5426211863739693,
FSO2013_Ratio H/M normalized Rep3___2,0.5287996225794319,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5205408238584956,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.544071233813621,0.35439314599079785
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5649467880349754,0.3877166966279148
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5461958429982671,0.3792550226030665
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5371968798628531,
AH2018_SILAC_MR_2_C,0.5287336819786648,
LATM2013_Log2 Ratio (Medium/Light) Forward,0.5360747830770342,
PG2020_Intensity 2h_A,0.5238842640436908,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5350437810609918,
JJ2018_Ratio H/M normalized___1,0.5307102889323065,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5400434712133327,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.55569383463155,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5511479732417998,0.3719488452539833
KBE2022_Log2_Ex_29_U,0.5319962333243634,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5355065309860855,
AH2018_LFQ_IT_4_N,0.522267147881242,
CK2022_15 200-1,0.557775847849442,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5308459970738524,
JJ2018_Ratio M/L normalized pP3___1,0.5293434768425114,
KBE2022_Log2_Ex_34_T,0.5353429911142541,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5363539851716096,
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.5409514283064579,
CK2022_2 200-1,0.5541897336336611,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5486737382423507,0.3701027124403684
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5215084245120968,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.551237984008718,
KBE2022_Log2_Ex_44_U,0.5366197412085688,
WZ2023_Pe_010_20min,0.5517929876110497,0.3783569126835393
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5461163095485032,
FSO2013_Ratio H/M normalized Rep3___1,0.522103396318998,0.3762698286082137
AH2018_SILAC_M_3_C,0.5241283290066624,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5306462259614222,
AH2018_SILAC_M_2_X,0.5248696934015697,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.542208448166704,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5472409511228014,0.3630108456649721
PG2020_Intensity 6h_C,0.5330061114437638,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5354971354965694,
AH2018_LFQ_M_3_N,0.5399796807778101,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5386756498416122,0.3605395998897879
CK2022_15 16-1,0.5300666121403963,
CK2022_3 16-1,0.5258825149818246,
LY2019_P4-,0.5395177372131257,
FSO2013_Ratio H/L normalized Rep3___2,0.5327649612252024,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5452080054063926,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5311906511254908,
CK2022_10 16-1,0.5320694980947068,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,0.5374522441395917,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5308303113396149,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5328205042799121,
AR2021_L41 10 μM,0.5547478163601669,
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5329358361449491,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5323443362733259,
ZX2022_CB treated Replicate 1,0.5248242889618779,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5426419471335423,0.3711358858842719
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5336927111390571,0.3606579006629358
AR2021_L41 1 μM,0.5284680501820588,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5344454056748267,0.3656628363991658
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5241709094898631,
KS2014_Intensity C4,0.540381102963906,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5314616487579227,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.5323672075139123,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,0.5359286268181825,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5424763675698554,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.546528320800874,
FSO2013_Ratio H/M normalized Rep2___3,0.5006985605413717,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5385988367724991,
WZ2023_Pu_025_10min,0.5383622805434903,0.3439875465852111
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5306010063665297,0.35708446876529076
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5291326119970594,
JJ2018_Ratio H/L normalized pP1___1,0.5283440112957518,
WZ2023_Pe_010_30min,0.553414509887466,0.3801907039999645
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5224281603272841,
KS2014_Intensity C6,0.5404278357240068,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5337863483729203,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5294040128582035,
JJ2018_Ratio H/M normalized pP1,0.5276436783926639,
CK2022_16 40-1,0.5337281429044781,
AH2018_SILAC_IT_2_C,0.5397073633482079,
CK2022_5 40-1,0.5337871990941173,
AH2018_LFQ_3_X,0.5304597286665466,
UK2020_UA_3,,
LY2019_P7-,0.5306138017627196,
GF2025_P5_Adh,0.5426623239117326,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5566033007794212,0.38579564671371325
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5465266371127784,0.39011829989184776
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5339262385463738,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5274462007347376,0.3694410218350377
PG2020_Intensity CT_B,0.5123360743516822,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5261390280739333,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5372742650723963,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,0.5338252313194255,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5236211780162832,
YA2020_Reporter_intensity_Cancer_No.4,0.5516785177166588,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5298829885679536,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.535402102313303,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5335454487450549,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5314500956918716,
AST2020_anti-CD3+PDL2,0.5562081037612842,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5358480088929981,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.5291446167316474,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.528430875683376,
AH2018_TMTMS2_1_X,0.5307094315398917,0.36107175499527844
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,0.5322730024905769,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,0.5354812749194612,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5295103478126352,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5362904626024898,
PG2020_Intensity 10h_B,0.5360217551210463,
AH2018_TMTMS3_1_X,0.5302869877479067,
CF2017_FTE 14,0.5330612883548793,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,0.5584821565890581,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5240821209682227,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.534489069968736,
EP2017_Untreated R#2 normalized log2 ratio,0.5272889832596137,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5395392384803179,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5077971861244355,
AS2011_Ratio H/L Normalized RNAi_2_1,,
